Read through compounds (RTCs) are chemical agents that promote the continuation of protein synthesis despite the presence of premature termination codons (PTCs) in the mRNA transcript. These PTCs typically lead to truncated, often non-functional proteins, which can result in various genetic disorders. RTCs work by enabling the ribosome to bypass these faulty stop signals, allowing for the production of full-length, functional proteins.
